Respiratory - commissioning policies
Please click on the links below to access the commissioning policies. The associated Equality Impact Assessments, if currently available, are accessible here.

The CCGs’ position on the implementation of policies affecting patient referral can be found here.
Aclidinium inhalation powder for Chronic Obstructive Pulmonary DiseaseClick here to download this file
Add this document to cartFluticasone furoate and vilanterol trifenatate (Relvar® Ellipta®) combination inhaler for asthmaClick here to download this file
Add this document to cartFluticasone furoate and vilanterol trifenatate (Relvar® Ellipta®) combination inhaler for Chronic Obstructive Pulmonary DiseaseClick here to download this file
Add this document to cartFlutiform® for the treatment of asthma in adults and children over 12 yearsClick here to download this file
Add this document to cartGlycopyrronium inhalation powder therapy for Chronic Obstructive Pulmonary DiseaseClick here to download this file
Add this document to cartIndacaterol inhalation powder hard capsules for Chronic Obstructive Pulmonary diseaseClick here to download this file
Add this document to cart
Please note:  Some commissioning policies approved by the previous commissioning organisations are yet to be reviewed and updated. There is an on-going programme of work in place to review and update these policies. They will then be published under the appropriate category. 

In the meantime they are still applicable to Northern, Eastern and Western Devon CCG. Former NHS Devon policies can be accessed here
Rate this Page.
Great
Okay
Bad